Angela Carlani

Use of Cytology, E6/E7 mRNA, and p16^INK4a–Ki-67 to Define the Management of Human Papillomavirus (HPV)–Positive Women in Cervical Cancer Screening

Daniela Gustinucci, Paolo Giorgi Rossi, Elena Cesarini et al. · American Journal of Clinical Pathology · 2015 · 59 citations · Full text

Medicine, Oncology, Pathology +17

Role of p16INK4a Cytology Testing as an Adjunct to Enhance the Diagnostic Specificity and Accuracy in Human Papillomavirus-Positive Women within an Organized Cervical Cancer Screening Program

Daniela Gustinucci, Basilio Passamonti, Elena Cesarini et al. · Acta Cytologica · 2012 · 34 citations

Medicine, Oncology, Pathology +17

A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer

Basilio Passamonti, Morena Malaspina, Callum G. Fraser et al. · Gut · 2016 · 34 citations · Full text

Medicine, Oncology, Preventive Medicine +15

Cervical human papilloma virus (HPV) DNA primary screening test: Results of a population-based screening programme in central Italy

Basilio Passamonti, Daniela Gustinucci, Paolo Giorgi Rossi et al. · Journal of Medical Screening · 2016 · 30 citations

Medicine, Pathology, Public Health Practice +17

Expression of p16 in abnormal pap-tests as an indicator of CIN2+ lesions: a possible role in the low grade ASC/US and L/SIL (Ig) cytologic lesions for screening prevention of uterine cervical tumours.

Basilio Passamonti, Daniela Gustinucci, P Recchia et al. · PubMed · 2010 · 12 citations

Medicine, Gynecology, Pathology +17